F19.180 Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder

Name of the Condition

• Other Psychoactive Substance Abuse with Psychoactive Substance-Induced Anxiety Disorder
• ICD-10 Code: F19.180

Summary

This condition involves the abuse of psychoactive substances not classified in other specific categories, accompanied by anxiety symptoms directly induced by the substance use. The abuse pattern is recurrent and leads to clinically significant impairment or distress, with anxiety symptoms arising as a direct physiological or psychological effect of the substance.

Causes

The causes can include recreational or non-medical use of psychoactive substances, psychological factors, peer pressure, or environmental influences. The induced anxiety disorder results from the substance's direct effects on the central nervous system, rather than from an independent mental health condition.

Risk Factors

• History of substance use disorders
• Mental health conditions (e.g., depression, anxiety)
• Social or peer influences
• Access to psychoactive substances
• Family history of substance abuse

Symptoms

• Recurrent substance use leading to failure to fulfill major roles
• Use in hazardous situations (e.g., driving under the influence)
• Increased tolerance or withdrawal symptoms
• Continued use despite social or interpersonal problems
• Anxiety symptoms (e.g., restlessness, excessive worry, panic) directly linked to substance use

Diagnosis

Diagnosis requires a clinical assessment by a healthcare professional, including a detailed history of substance use and its impact on daily functioning. No specific lab tests are used, but substance screening may support the evaluation. The anxiety symptoms must be directly attributable to the substance use and not better explained by another mental health disorder.

Treatment Options

Treatment typically involves a combination of behavioral therapies (e.g., Cognitive Behavioral Therapy) to address substance use and anxiety, along with possible pharmacotherapy to manage withdrawal or anxiety symptoms. Supportive care and referral to specialized substance use programs may also be recommended.

Prognosis and Follow-Up

Prognosis depends on the severity of substance use and the individual's response to treatment. Regular follow-up is important to monitor for relapse, manage anxiety symptoms, and adjust treatment as needed. Long-term recovery often requires ongoing support and lifestyle modifications.

Complications

• Worsening of anxiety symptoms
• Increased risk of substance dependence
• Social or occupational impairment
• Potential for co-occurring mental health disorders
• Physical health issues related to substance use

Lifestyle & Prevention

• Avoiding non-medical use of psychoactive substances
• Seeking healthy coping mechanisms for stress or anxiety
• Building a strong support network
• Engaging in regular physical activity and stress-reduction practices
• Educating oneself about the risks of substance use

When to Seek Professional Help

Seek help if substance use is interfering with daily life, if anxiety symptoms are severe or persistent, or if there are signs of withdrawal or dependence. Early intervention can improve outcomes and prevent complications.

Tips for Medical Coders

When coding F19.180, ensure documentation clearly links the anxiety disorder to the psychoactive substance use. The code requires evidence that the anxiety symptoms are directly induced by the substance, not an independent condition. Include details about the substance type (if known) and the duration or pattern of use to support accurate coding.